The co-expression of PML/RARα and AML1/ETO fusion genes is associated with ATRA resistance [2]

British Journal of Haematology

Volumn 128, Issue 3, 2005, Pages 407-409

  Abreu E Lima, Rodrigo Siqueira ^a   Rozera Baruffi, Marcelo ^a   Gouveia De Lima, Ana Sílvia ^a   De Oliveira, Fábio Morato ^a   De Figueiredo Pontes, Lorena Lôbo ^a   Gonzaga Tone, Luiz ^a   Rogatto, Sílvia Regina ^b   Passetto Falcão, Roberto ^a   Ferrari Chauffaille, Maria De Lourdes L ^a   Rego, Eduardo M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Acute myeloid leukaemia; Acute promyelocytic leukaemia; Chromosomal translocation; Cytogenetics; Spectral karyotyping

Indexed keywords

CYTARABINE; DAUNORUBICIN; HYBRID PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN RETINOIC ACID RECEPTOR ALPHA FUSION PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX1 ETO FUSION PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; BLOOD CELL COUNT; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CAUSE OF DEATH; CELL STRUCTURE; CELL SUBPOPULATION; CHROMOSOME 15; CHROMOSOME G BAND; CLINICAL FEATURE; CYTOGENETICS; FEMALE; FUSION GENE; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; LETTER; LEUKEMIA CELL; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MYELODYSPLASIA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTRAL KARYOTYPING;

ANTINEOPLASTIC AGENTS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; LEUKEMIA, PROMYELOCYTIC, ACUTE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; RECEPTORS, RETINOIC ACID; TRANSCRIPTION FACTORS; TRETINOIN;

EID: 13444270403     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05343.x     Document Type: Letter

References (7)

1. Biondi, A., Rambaldi, A., Alcalay, M., Pandolfi, P.P., Lo Coco, F., Diverio, D., Rossi, V., Mencarelli, A., Longo, L, Zangrilli, D., Masera, G., Barbui, T., Mandelli, F., Grignani, F. & Pelicci, G. (1999) RARα gene rearrangements as a genetic marker for diagnosis and monitoring in acute promyelocytic leukemia. Blood, 77, 1418-1422.
2. Bonomi, R., Giordano, H., Moreno, P., Gallagher, R.E. & Uriarte, M.R. (1998) Chimeric M3:M2 case of acute promyelocytic leukemia (APL): differential responses to all-trans retinoic acid (ATRA) and chemotherapy. Blood, 92(Suppl. 1), 2492 (abstract).
3. Charin, C., Ritouet, D., Campos, L., Devaux, Y., Archimbaud, E., Fraisse, J., Fiere, D. & Germain, D. (1992) Association of t(15;17) and t(8;21) in the initial phase of an acute promyelocytic leukemia. Cancer Genetics and Cytogeneticts, 58, 96-99.
4. van Dongen, J.J.M., Macintyre, E.A., Gaben, J.A., Delabesse, E., Rossi, V., Saglio, G., Gottardi, E., Rambaldi, A., Dotti, G., Griesinger, F., Parreira, A., Gameiro, P., González-Diáz, M., Malec, M., Langerak, A.W., San Miguel, J.F. & Biondi, A. (1999) Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Leukemia, 13, 1901-1928.
5. Movafagh, A., Varma, N. & Varma, S. (1996) Co-expression of two FAB-specific chromosome changes, t(15;17) and t(8;21), in a case of acute promyelocytic leukemia. Annals of Hematology, 72, 375-377.
6. Sttavroyianni, N., Kalmantis, T. & Yataganas, X. (2003) Simultaneous PML/RARα and AML1/ETO gene rearrangements in a patient with acute myeloid leukemia, Haematologica, 88, 1294-1295.
7. Varella-Garcia, M., Brizard, F., Roche, J., Flandrin, G., Drabkin, H. & Brizard, A. (1999) AML1/ETO and PML/RARα rearrangements in a case of AML-M2 acute myeloblastic leukemia with t(15;17). Leukemia and Lymphoma, 33, 403-406.